Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  241 results for ""Tazobactam""

Your Filters

Subject : meropenem Filter by : Title
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Empirical meropenem versus piperacillin/tazobactam for adult patients with sepsis (EMPRESS) trial: Protocol.

  • Authors : Granholm A; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.

Subjects: Meropenem*/Meropenem*/Meropenem*/therapeutic use ; Meropenem*/Meropenem*/Meropenem*/administration & dosage ; Sepsis*/Sepsis*/Sepsis*/drug therapy

  • Source: Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2024 Sep; Vol. 68 (8), pp. 1107-1119. Date of Electronic Publication: 2024 May 20.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0370270 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial.

Subjects: Meropenem*/Meropenem*/Meropenem*/therapeutic use ; Meropenem*/Meropenem*/Meropenem*/pharmacology ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/therapeutic use

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1482-1489.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Meropenem versus piperacillin-tazobactam for the treatment of pancreatic necrosis.

  • Authors : Racketa S; AdventHealth Daytona Beach, Department of Pharmacy, 301 Memorial Medical Pkwy., Daytona Beach, FL 32117, USA. Electronic address: .; Gandhi K

Subjects: Meropenem*/Meropenem*/Meropenem*/therapeutic use ; Meropenem*/Meropenem*/Meropenem*/administration & dosage ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/therapeutic use

  • Source: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2024 Jun; Vol. 109 (2), pp. 116209. Date of Electronic Publication: 2024 Feb 10.Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect modification of dosing strategy (AUC or trough) on AKI associated with vancomycin in combination with piperacillin/tazobactam or cefepime and meropenem.

  • Authors : Mefford B; Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky, USA.; Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.

Subjects: Vancomycin*/Vancomycin*/Vancomycin*/adverse effects ; Vancomycin*/Vancomycin*/Vancomycin*/administration & dosage ; Vancomycin*/Vancomycin*/Vancomycin*/therapeutic use

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 May 02; Vol. 68 (5), pp. e0108523. Date of Electronic Publication: 2024 Apr 12.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.

  • Authors : Fouad A; Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT, USA.; Nicolau SE

Subjects: Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects ; Cephalosporins*/Cephalosporins*/Cephalosporins*/pharmacology ; Meropenem*/Meropenem*/Meropenem*/pharmacology

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 May 02; Vol. 79 (5), pp. 1176-1181.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study.

Subjects: Meropenem*/Meropenem*/Meropenem*/adverse effects ; Meropenem*/Meropenem*/Meropenem*/pharmacology ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/adverse effects

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Dec 06; Vol. 73 (11), pp. e3842-e3850.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury.

  • Authors : Aslan AT; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey. .; Pashayev T

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*etiology ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*adverse effects ; Kidney/Kidney/Kidney/*drug effects

  • Source: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2021 Sep; Vol. 40Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-4373

Record details

Read More Add to Saved list
×
Academic Journal

Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.

  • Authors : Timsit JF; Intensive Care Medicine Department, Université Paris Diderot, Paris, France.; Huntington JA

Subjects: Cephalosporins/Cephalosporins/Cephalosporins/*standards ; Healthcare-Associated Pneumonia/Healthcare-Associated Pneumonia/Healthcare-Associated Pneumonia/*drug therapy ; Meropenem/Meropenem/Meropenem/*standards

  • Source: Critical care (London, England) [Crit Care] 2021 Aug 11; Vol. 25 (1), pp. 290. Date of Electronic Publication: 2021 Aug 11.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?

  • Authors : Esteve-Pitarch E; Department of Pharmacy, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Meropenem/Meropenem/Meropenem/*administration & dosage ; Piperacillin, Tazobactam Drug Combination/Piperacillin, Tazobactam Drug Combination/Piperacillin, Tazobactam Drug Combination/*administration & dosage

  • Source: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2021 Jul; Vol. 46 (4), pp. 527-538. Date of Electronic Publication: 2021 Jun 15.Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin/tazobactam as a 1-h drip infusion four times a day.

  • Authors : Kobayashi R; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, 6-6 Higashi-Sapporo, Shiroishiku, Sapporo, 003-0006, Japan. .; Sano H

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Bacteremia/Bacteremia/Bacteremia/*drug therapy ; Febrile Neutropenia/Febrile Neutropenia/Febrile Neutropenia/*drug therapy

  • Source: International journal of hematology [Int J Hematol] 2021 Mar; Vol. 113 (3), pp. 430-435. Date of Electronic Publication: 2020 Nov 10.Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  241 results for ""Tazobactam""